We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Metabolic Autopsy May Explain Some SIDS Cases

By HospiMedica staff writers
Posted on 26 Jul 2001
Metabolic autopsy using tandem mass spectrometry (MS/MS) may explain some sudden infant death syndrome (SIDS) cases, according to a study published in the July 2001 issue of Clinical Chemistry.

Researchers obtained postmortemn blood specimens from 7,058 infants and used MS/MS to obtain acylcarnitine and amino acid profiles. More...
Specialized interpretation was used to evaluate profiles for disorders of fatty acid, organic acid, and amino acid metabolism. The analyses were compared with the analyses of bile specimens, newborn blood specimens, and specimens obtained from older infants at risk for metabolic disorders.

Results on 66 specimens suggested diagnoses of metabolic disorders. The researchers, from Neo Gen Screening (Bridgeville, PA, USA; www.neogenscreening), point out that without postmorten examination with MS/MS, the deaths from inherited metabolic disorders would have remained undiagnosed. This examination would not only provide a family with a plausible cause of their infant's death but could also serve to prevent morbidity and mortality in asymptomatic but affected siblings. Therefore, the researchers urge medical examiners and pathologists to consider an MS/MS analysis in all cases of infant deaths that are unexpected or of unknown cause.




Related Links:
Neo Gen Screening
Clinical Chemistry

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.